Mi az ára D. Western Therapeutics Institute, Inc. (4576)

D. Western Therapeutics Institute, Inc. (4576) ára $0.56109583

Mi a D. Western Therapeutics Institute, Inc. (4576 piaci tőkésítése)

D. Western Therapeutics Institute, Inc. piaci tőkésítése (4576) $32.25M

D. Western Therapeutics Institute, Inc. (4576) P/B mutató

D. Western Therapeutics Institute, Inc. is a biotechnology enterprise focused on the research, discovery, and innovation of various pharmaceutical drugs. The company's current portfolio includes GLANATEC and GLA-ALPHA, ophthalmic solutions prescribed for glaucoma and ocular hypertension, as well as DW-1001, another medication for eye conditions. It also provides DWR-2206, a regenerative cell-based product targeting bullous keratopathy, and DW-1002, an ophthalmic surgical aid used for staining membranes like ILM, ALC, ERM, and PVR during cataract operations. In its development pipeline, the company is advancing DW-5LBT, a lidocaine patch designed to alleviate neuropathic pain post-shingles. Additionally, K-321 is progressing through Phase III clinical trials for Fuch endothelial corneal dystrophy, and H-1337, a multi-kinase inhibitor, has commenced Phase IIb trials for glaucoma and ocular hypertension treatment. The firm was established in 1999 and operates from its headquarters in Nagoya, Japan.

Év	P/B arány	Változtassa meg
Nincs elég adat a megadott dátumokhoz.

Év

P/B arány

Változtassa meg

Nincs elég adat a megadott dátumokhoz.

Vállalat	P/B arány	P/B arány különbség	Ország
Vertex Pharmaceuticals Incorporated VRTX.US	6.3419	-	US
Moderna, Inc. MRNA.US	3.7087	-	US
Argenx SE ARGX.US	6.2413	-	NL
CSL Limited CSL.AX	2.5054	-	AU
Lonza Group AG LONN.SW	-	-	CH

Vállalat

P/B arány

P/B arány különbség

Ország